ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,900Medicare Part D Prescriptions Filled, Including Refills

Rank: 343 out of 1677

$590K Total Retail Price of All Prescriptions

Rank: 263 out of 1677

287 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 287 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 287 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 8,922 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
WARFARIN SODIUM 377 349 1 24
AMLODIPINE BESYLATE 350 342 2 2
LISINOPRIL 320 299 3 3
DONEPEZIL HCL 301 297 4 30
OMEPRAZOLE 266 242 5 6
NAMENDA 262 262 6 39
SIMVASTATIN 259 251 7 1
FUROSEMIDE 244 231 8 8
HYDROCODONE-ACETAMINOPHEN 243 224 S3 9 4
TRAMADOL HCL 213 194 10 16
METOPROLOL TARTRATE 203 172 11 12
MIRTAZAPINE 199 176 12 62
LEVOTHYROXINE SODIUM 183 162 13 5
GABAPENTIN 165 151 14 11
FAMOTIDINE 148 122 15 41
NOVOLOG 144 126 16 117
LANTUS 137 127 17 44
CARVEDILOL 127 124 18 20
PRAVASTATIN SODIUM 109 99 19 10
ATORVASTATIN CALCIUM 107 103 20 13
EXELON 101 98 21 119
SERTRALINE HCL 99 84 22 26
ZOLPIDEM TARTRATE 98 98 23 15
TRAZODONE HCL 94 93 24 37
RANITIDINE HCL 91 74 25 18
HYDROCHLOROTHIAZIDE 90 85 26 9
CITALOPRAM HBR 86 67 27 22
OXYCODONE-ACETAMINOPHEN 82 70 S2 28 122
METOPROLOL SUCCINATE 79 60 29 23
KLOR-CON M20 78 78 30 65
ESCITALOPRAM OXALATE 77 72 31 80
QUETIAPINE FUMARATE 75 72 32 77
LEVETIRACETAM 75 46 32 116
HYDRALAZINE HCL 72 56 34 69
CLONIDINE HCL 72 60 34 36
ATENOLOL 71 70 36 21
CLOPIDOGREL 70 70 37 32
ALLOPURINOL 65 62 38 31
METFORMIN HCL 60 60 39 7
NOVOLIN R 60 56 39 133
FENTANYL 60 56 S2 39 103
LOSARTAN POTASSIUM 58 56 42 25
POLYETHYLENE GLYCOL 3350 52 42 43 76
FLUOXETINE HCL 52 48 43 49
PANTOPRAZOLE SODIUM 51 48 45 46
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 9, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.